Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date08 May 2008 |
100 Clinical Results associated with Guangzhou Baiyunshan Biological Technology Limited
0 Patents (Medical) associated with Guangzhou Baiyunshan Biological Technology Limited
100 Deals associated with Guangzhou Baiyunshan Biological Technology Limited
100 Translational Medicine associated with Guangzhou Baiyunshan Biological Technology Limited